X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (4) 4
double-blind method (4) 4
drug therapy (4) 4
female (4) 4
hiv infections - drug therapy (4) 4
humans (4) 4
index medicus (4) 4
antiviral agents (3) 3
clinical trials (3) 3
hiv infection (3) 3
hiv infections - virology (3) 3
human immunodeficiency virus--hiv (3) 3
male (3) 3
middle aged (3) 3
viral load (3) 3
abridged index medicus (2) 2
adults (2) 2
analysis (2) 2
antiretroviral drugs (2) 2
drug dosages (2) 2
emtricitabine (2) 2
emtricitabine - adverse effects (2) 2
emtricitabine - therapeutic use (2) 2
heterocyclic compounds, 3-ring - adverse effects (2) 2
hiv (2) 2
hiv integrase inhibitors - administration & dosage (2) 2
hiv integrase inhibitors - adverse effects (2) 2
hiv-1 - isolation & purification (2) 2
infections (2) 2
infectious disease (2) 2
infectious diseases (2) 2
initial treatment (2) 2
medicine, general & internal (2) 2
rna, viral - blood (2) 2
safety (2) 2
tenofovir - adverse effects (2) 2
tenofovir - therapeutic use (2) 2
treatment outcome (2) 2
abacavir (1) 1
acquired immune deficiency syndrome--aids (1) 1
active antiretroviral therapy (1) 1
adolescent (1) 1
adverse events (1) 1
aged (1) 1
aids/hiv (1) 1
anti-hiv agents (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
anti-retroviral agents - administration & dosage (1) 1
anti-retroviral agents - adverse effects (1) 1
anti-retroviral agents - therapeutic use (1) 1
antiretroviral agents (1) 1
antiretroviral therapy (1) 1
antiretroviral therapy, highly active (1) 1
antiretroviral therapy, highly active - methods (1) 1
article (1) 1
atazanavir sulfate - administration & dosage (1) 1
atazanavir sulfate - adverse effects (1) 1
atazanavir sulfate - therapeutic use (1) 1
canada (1) 1
clinical-trials (1) 1
co-formulated elvitegravir (1) 1
cobicistat (1) 1
cobicistat - administration & dosage (1) 1
cobicistat - adverse effects (1) 1
cobicistat - therapeutic use (1) 1
comparative analysis (1) 1
cross-resistance (1) 1
daily elvitegravir (1) 1
dna polymerases (1) 1
dolutegravir (1) 1
dosage and administration (1) 1
double-blind (1) 1
drug administration schedule (1) 1
drug resistance (1) 1
drug resistance, viral (1) 1
drug therapy, combination (1) 1
efavirenz (1) 1
emtricitabine - administration & dosage (1) 1
emtricitabine/tenofovir df (1) 1
exposure (1) 1
gender (1) 1
gsk1265744 (1) 1
health aspects (1) 1
health care (1) 1
hepatitis (1) 1
heterocyclic compounds, 3-ring - administration & dosage (1) 1
heterocyclic compounds, 3-ring - therapeutic use (1) 1
highly active antiretroviral therapy (1) 1
hiv integrase inhibitors - therapeutic use (1) 1
hiv protease inhibitors - administration & dosage (1) 1
hiv protease inhibitors - adverse effects (1) 1
hiv protease inhibitors - therapeutic use (1) 1
hiv-1 (1) 1
hiv-1 infection (1) 1
immunology (1) 1
infection (1) 1
inhibitors (1) 1
insomnia (1) 1
integrase inhibitors (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1145 - 1155
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9893, pp. 700 - 708
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2016, Volume 3, Issue 9, pp. e410 - e420
Summary Background Women are under-represented in HIV antiretroviral therapy (ART) studies. Guidelines for selection of ART as initial therapy in patients with... 
Infectious Disease | UNITED-STATES | INFECTIOUS DISEASES | TENOFOVIR DISOPROXIL FUMARATE | TREATMENT-NAIVE | ACTIVE ANTIRETROVIRAL THERAPY | CLINICAL-TRIALS | INITIAL TREATMENT | GENDER | SEX-DIFFERENCES | IMMUNOLOGY | HIV-1 INFECTION | ADVERSE EVENTS | Atazanavir Sulfate - administration & dosage | Humans | RNA, Viral - blood | Tenofovir - administration & dosage | HIV Integrase Inhibitors - administration & dosage | Atazanavir Sulfate - adverse effects | Viral Load | Quinolones - adverse effects | Ritonavir - adverse effects | Quinolones - therapeutic use | Ritonavir - therapeutic use | Adult | Female | Emtricitabine - administration & dosage | HIV Protease Inhibitors - adverse effects | Emtricitabine - adverse effects | Emtricitabine - therapeutic use | Tenofovir - adverse effects | Double-Blind Method | Ritonavir - administration & dosage | Tenofovir - therapeutic use | HIV Infections - virology | Cobicistat - administration & dosage | International Cooperation | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Antiretroviral Therapy, Highly Active | Atazanavir Sulfate - therapeutic use | Quinolones - administration & dosage | HIV Integrase Inhibitors - adverse effects | HIV Integrase Inhibitors - therapeutic use | Cobicistat - adverse effects | HIV Infections - drug therapy | Cobicistat - therapeutic use
Journal Article
by Cahn, Pedro and Madero, Juan Sierra and Arribas, José Ramón and Antinori, Andrea and Ortiz, Roberto and Clarke, Amanda E and Hung, Chien-Ching and Rockstroh, Jürgen K and Girard, Pierre-Marie and Sievers, Jörg and Man, Choy and Currie, Alexander and Underwood, Mark and Tenorio, Allan R and Pappa, Keith and Wynne, Brian and Fettiplace, Anna and Gartland, Martin and Aboud, Michael and Smith, Kimberly and Cassetti, Lidia and David, Daniel and Figueras, Laura and Losso, Marcelo and Lopardo, Gustavo and Lupo, Sergio and Porteiro, Norma and Sánchez, Marisa and Bloch, Mark and Cooper, David and Finlayson, Robert and Kelleher, Anthony and Koh, Kenneth and Lewis, David and McMahon, James and Moore, Richard and Roth, Norman and Shields, Matthew and De Wit, Stephane and Florence, Eric and Goffard, Jean-Christophe and Demeester, Remy and Lacor, Patrick and Vandercam, Bernard and Vandekerckhove, Linos and Angel, Jonathan and Baril, Jean-Guy and Conway, Brian and De Pokomandy, Alexandra and Szabo, Jason and Walmsley, Sharon and Bouchaud, Olivier and Chidiac, Christian and Delobel, Pierre and Goujard, Cecile and Katlama, Christine and Molina, Jean-Michel and Pialoux, Gilles and Philibert, Patrick and Bogner, Johannes and Esser, Stefan and Krznaric, Ivanka and Lehmann, Clara and Spinner, Christoph and Stellbrink, Hans-Jurgen and Stephan, Christoph and Stoehr, Albrecht and Barchi, Enrico and Caramello, Pietro and Castelli, Francesco and Cattelan, Anna Maria and D'Arminio Monforte, Antonella and Di Biagio, Antonio and Di Perri, Giovanni and Gori, Andrea and Maggiolo, Franco and Menzaghi, Barbara and Migliorino, Guglielmo and Mussini, Cristina and Penco, Giovanni and Puoti, Massimo and Rizzardini, Giuliano and Gulminetti, Roberto and Lazzarin, Adriano and Quirino, Tiziano and Sighinolfi, Laura and Viale, Pierluigi and Amaya Tapia, Gerardo and Andrade Villanueva, Jaime and Granados Reyes, Enrique R and Perez Rios, Alma and Santoscoy Gomez, Mario and Den Hollander, Jan and Rijnders, Bart and Hidalgo, José A and Hercilla Vasquez, Luis and Illescas, Luis and Olczak, Anita and Mansinho, Kamal and Correia Pacheco, Patricia Paula and ... and GEMINI Study Team
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 143 - 155
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.